The activity of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats

Journal of Veterinary Medical Science

Volumn 68, Issue 2, 2006, Pages 105-111

  Kawai, Kouji ^a   Uetsuka, Koji ^a   Doi, Kunio ^a   Nakayama, Hiroyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Canine; Mammary tumor; MMP; Rat; TIMP

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BREAST TUMOR; CARCINOMA; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; SPRAGUE DAWLEY RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOMA; ANIMALS; BREAST NEOPLASMS; CARCINOMA; DOG DISEASES; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASES;

CANIS FAMILIARIS;

EID: 33644784614     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.105     Document Type: Article

References (29)

1. Brodey, R. S., Goldschmidt, M. H. and Roszl, J. R. 1983. Canine mammary gland neoplasms. J. Am. Anim. Hosp. Assoc. 19: 61-90.
2. Garbett, E. A., Reed, M. W. and Brown, N. J. 1999. Proteolysis in human breast and colorectal cancer. Br. J. Cancer 81: 287-293.
3. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. and Iwata, K. 1992. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298: 29-32.
4. Hirahara, F., Miyagi, Y., Miyagi, E., Yasumitsu, H., Koshikawa, N., Nagashima, Y., Kitamura, H., Minaguchi, H., Umeda, M. and Miyazaki, K. 1995. Trypsinogen expression in human ovarian carcinomas. Int. J. Cancer 63: 176-181.
5. Huggins, C., Grand, L. C. and Brillantes, F. P. 1961. Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature (Lond.) 189: 204-207.
6. Iwata, H., Kobayashi, S., Iwase, H., Masaoka, A., Fujimoto, N. and Okada, Y. 1996. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn. J. Cancer Res. 87: 602-611.
7. Iwata, H., Yamamoto, M., Nemori, R., Mizutani, M., Iwase, T., Miura, S., Obata, Y., Hara, Y., Omoto, Y., Toyama, T., Yamashita, H., Iwase, H. and Kobayashi, S. 2001. Localization of gelatinolytic activity can be detected in breast cancer tissues by film in situ zymography. Breast Cancer 8: 111-115.
8. Kawamura, K., Kamiya, N., Suyama, T., Shimbo, M., Oosumi, N., Suzuki, H., Ueda, T., Tobe, T., Igarashi, T., Ito, H. and Ishikura, H. 2004. in situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer. J. Urol. 172: 1480-1484.
9. Kleiner, D. E. and Stetler-Stevenson, W. G. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Ann. Biochem. 218: 325-329.
10. Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. 2004. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49: 187-198.
11. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. and Shafie, S. 1980. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.) 284: 67-68.
12. Liotta, L. A., Stetler-Stevenson, W. G. and Steeg, P. S. 1991. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 9: 543-551.
13. Loukopoulos, P., Mungall, B. A., Straw, R. C., Thornton, J. R. and Robinson, W. F. 2003. Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet. Pathol. 40: 382-394.
14. Luparello, C., Avanzato, G., Carella, C. and Pucci-Minafra, I. 1999. Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res. Treat. 54: 235-244.
15. Matrisian, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 121-125.
16. Misdorp, W., Else, R. W., Hellemen, E. and Lipscomb, T. P. 1999. Histological Classification of Mammary Tumors of the Dog and the Cat, World Health Organization International Histological Classification of Tumors of Domestic Animals, Second Series Volume VII, AFIP, Washington, D.C.
17. Nemeth, J. A., Rafe, A., Steiner, M. and Goolsby, C. L. 1996. TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin. Exp. Cell Res. 224: 110-115.
18. Oliver, G. W., Leferson, J. D., Stetler-Stevenson, W. G. and Kleiner, D. E. 1997. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Ann. Biochem. 244: 161-166.
19. Papparella, S., Restucci, B., Paciello, O. and Maiolino, P. 2002. Expression of matrix metalloprotease-2 (MMP-2) and the activator membrane type 1 (MT1-MMP) in canine mammary carcinomas. J. Comp. Pathol. 126: 271-276.
20. Rha, S. Y., Kim, J. H., Roh, J. K., Lee, K. S., Min, J. S., Kim, B. S. and Chung, H. C. 1997. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res. Treat. 43: 175-181.
21. Rha, S. Y., Yang, W. I., Kim, J. H., Roh, J. K., Min, J. S., Lee, K. S., Kim, B. S. and Chung, H. C. 1998. Different expression patterns of MMP-2 and MMP-9 in breast cancer. Oncol. Rep. 5: 875-879.
22. Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H., Wellings, S. R. and van Zwieten, M. J. 1990. Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62: 244-278.
23. Russo, J. and Russo, I. H. 2000. Atlas and histologic classification of tumors of the rat mammary gland. J. Mammary Gland Biol. Neoplasia 5: 187-200.
24. Takano, S., Tsuboi, K., Matsumura, A., Sato, H. and Nose, T. 2001. Localization of gelatinase activities in glioma tissues by film in situ zymography. Brain Tumor Pathol. 18: 145-150.
25. Woodhouse, E. C., Chuaqui, R. F. and Liotta, L. A. 1997. General mechanisms of metastasis. Cancer 80: 1529-1537.
26. Yamamoto, H., Iku, S., Itoh, F., Tang, X., Hosokawa, M. and Imai, K. 2001. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer 91: 1324-1331.
27. Yang, T. T. and Hawkes, S. P. 1992. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89: 10676-10680.
28. Yokota, H., Kumata, T., Taketaba, S., Kobayashi, T., Moue, H., Taniyama, H., Hirayama, K., Kagawa, Y., Itoh, N., Fujita, O., Nakade, T. and Yuasa, A. 2001. High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma. Biochim. Biophys. Acta 1568: 7-12.
29. Zheng, K., Nagai, Y., Kishimoto, T., Yamazawa, K., Tate, S., Nemori, R., Hirai, Y., Sekiya, S. and Ishikura, H. 2002. A quantitative evaluation of active gelatinolytic sites in uterine endometrioid adenocarcinoma using film in situ zymography: association of stronger gelatinolysis with myometrial invasion. Jpn. J. Cancer Res. 93: 516-522.